Grant supports extension of Part 1 of Phase 2 VacSYn trial of ACI-7104
Planned extension of Part 1 will assess long-term safety and efficacy of ACI-7104 for an additional 2 years
Final data from Part 1 of VacSYn trial expected in H2 2026
Lausanne, Switzerland, June 11, 2026 -- AC Immune SA (NASDAQ:ACIU), a clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, today announced it will receive a research grant of $4 million from The Vijay and Marie Goradia Charitable Foundation. The grant will support extending Part 1 of the ongoing Phase 2 VacSYn trial of ACI-7104, AC Immune's anti-alpha-synuclein (a-syn) active immunotherapy, in early Parkinson's disease (PD).
Houston businessman, philanthropist, and cancer survivor Vijay Goradia and his wife, Marie, established the Vijay and Marie Goradia Charitable Foundation to support health, education, and human services. The Foundation has previously awarded substantial grants to the University of Texas MD Anderson Cancer Center to speed translational research and clinical trials.
The long-term dataset enabled by this grant will be particularly valuable for individuals with prodromal and early PD, who will likely require prolonged treatment and are expected to benefit from a well-established long-term safety profile.
Vijay Goradia commented: "It is our hope that this grant will contribute to expanding our knowledge of PD and to bringing ACI-7104 to patients in the earliest stages of disease, before its symptoms have irreversibly changed the lives of patients and their families. If realized, its potential to slow the rate of progression would revolutionize the treatment of PD, preserving function and independence for individuals and bringing hope to millions. We are particularly excited and hopeful about the future potential for ACI-7104 to prevent PD, sparing other families from this disease altogether."
Dr. Andrea Pfeifer, CEO of AC Immune SA, commented: "We are honored to receive this grant from The Vijay and Marie Goradia Charitable Foundation. ACI-7104 ...
